Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Boulle

Showing results (81-90 of 240) with videos related to

Pageof 24
Sort By:
AIDS Care|November 3, 2020
Changing contextual factors from baseline to 9-months post-HIV diagnosis predict 5-year mortality in Durban, South AfricaIngrid V Bassett, Ai Xu, Janet Giddy, et al.
American Journal of Epidemiology|March 29, 2020
The Impact of Delayed Switch to Second-Line Antiretroviral Therapy on Mortality, Depending on Definition of Failure Time and CD4 Count at FailureHelen Bell-Gorrod, Matthew P Fox, Andrew Boulle, et al.
JAMA|August 5, 2008
Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapyAndrew Boulle, Gilles Van Cutsem, Karen Cohen, et al.
Plos One|February 11, 2026
An economic evaluation of the LINKEDin study: An intervention to reduce initial loss to follow-up among tuberculosis patients in South AfricaMichael Strauss, Muhammad Osman, Sue-Ann Meehan, et al.
Plos One|September 21, 2020
Identifying and predicting longitudinal trajectories of care for people newly diagnosed with HIV in South AfricaLaura Platt, Ai Xu, Janet Giddy, et al.
AIDS (London, England)|October 17, 2018
Projected population-wide impact of antiretroviral therapy-linked isoniazid preventive therapy in a high-burden settingEmily A Kendall, Andrew S Azman, Gary Maartens, et al.
Plos Medicine|April 29, 2009
Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortalityMartin W G Brinkhof, Andrew Boulle, Ralf Weigel, et al.
Plos Medicine|May 10, 2024
The cyclical cascade of HIV care: Temporal care engagement trends within a population-wide cohortJonathan Euvrard, Venessa Timmerman, Claire Marriott Keene, et al.
Plos One|June 12, 2013
Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort studyMhairi Maskew, Matthew P Fox, Gilles van Cutsem, et al.
AIDS (London, England)|March 8, 2016
Post-treatment effect of isoniazid preventive therapy on tuberculosis incidence in HIV-infected individuals on antiretroviral therapyTom Sumner, Rein M G J Houben, Molebogeng X Rangaka, et al.
Pageof 24

Showing results (81-90 of 240) with videos related to

Sort By:
Pageof 24
AIDS Care|November 3, 2020
Changing contextual factors from baseline to 9-months post-HIV diagnosis predict 5-year mortality in Durban, South AfricaIngrid V Bassett, Ai Xu, Janet Giddy, et al.
American Journal of Epidemiology|March 29, 2020
The Impact of Delayed Switch to Second-Line Antiretroviral Therapy on Mortality, Depending on Definition of Failure Time and CD4 Count at FailureHelen Bell-Gorrod, Matthew P Fox, Andrew Boulle, et al.
JAMA|August 5, 2008
Outcomes of nevirapine- and efavirenz-based antiretroviral therapy when coadministered with rifampicin-based antitubercular therapyAndrew Boulle, Gilles Van Cutsem, Karen Cohen, et al.
Plos One|February 11, 2026
An economic evaluation of the LINKEDin study: An intervention to reduce initial loss to follow-up among tuberculosis patients in South AfricaMichael Strauss, Muhammad Osman, Sue-Ann Meehan, et al.
Plos One|September 21, 2020
Identifying and predicting longitudinal trajectories of care for people newly diagnosed with HIV in South AfricaLaura Platt, Ai Xu, Janet Giddy, et al.
AIDS (London, England)|October 17, 2018
Projected population-wide impact of antiretroviral therapy-linked isoniazid preventive therapy in a high-burden settingEmily A Kendall, Andrew S Azman, Gary Maartens, et al.
Plos Medicine|April 29, 2009
Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortalityMartin W G Brinkhof, Andrew Boulle, Ralf Weigel, et al.
Plos Medicine|May 10, 2024
The cyclical cascade of HIV care: Temporal care engagement trends within a population-wide cohortJonathan Euvrard, Venessa Timmerman, Claire Marriott Keene, et al.
Plos One|June 12, 2013
Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort studyMhairi Maskew, Matthew P Fox, Gilles van Cutsem, et al.
AIDS (London, England)|March 8, 2016
Post-treatment effect of isoniazid preventive therapy on tuberculosis incidence in HIV-infected individuals on antiretroviral therapyTom Sumner, Rein M G J Houben, Molebogeng X Rangaka, et al.
Pageof 24